Cellular and Molecular Mechanisms of Pathogenic and Protective Immune Responses to SARS-CoV-2 and Implications of COVID-19 Vaccines
- PMID: 36992199
- PMCID: PMC10053541
- DOI: 10.3390/vaccines11030615
Cellular and Molecular Mechanisms of Pathogenic and Protective Immune Responses to SARS-CoV-2 and Implications of COVID-19 Vaccines
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has devastated the world with coronavirus disease 2019 (COVID-19), which has imparted a toll of at least 631 million reported cases with 6.57 million reported deaths. In order to handle this pandemic, vaccines against SARS-CoV-2 have been developed and billions of doses of various vaccines have been administered. In the meantime, several antiviral drugs and other treatment modalities have been developed to treat COVID-19 patients. At the end of the day, it seems that anti-SARS-CoV-2 vaccines and newly developed antiviral drugs may be improved based on various new developments. COVID-19 represents a virus-induced, immune-mediated pathological process. The severity of the disease is related to the nature and properties of the host immune responses. In addition, host immunity plays a dominant role in regulating the extent of COVID-19. The present reality regarding the role of anti-SARS-CoV-2 vaccines, persistence of SARS-CoV-2 infection even three years after the initiation of the pandemic, and divergent faces of COVID-19 have initiated several queries among huge populations, policy makers, general physicians, and scientific communities. The present review aims to provide some information regarding the molecular and cellular mechanisms underlying SARS-CoV-2 infection.
Keywords: COVID-19; SARS-CoV-2; immunity; pathogenic; protective.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants.Viruses. 2022 Nov 17;14(11):2541. doi: 10.3390/v14112541. Viruses. 2022. PMID: 36423150 Free PMC article. Review.
-
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949. Cells. 2021. PMID: 34831172 Free PMC article. Review.
-
Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.Curr Mol Med. 2022;22(7):621-639. doi: 10.2174/1566524021666211013121831. Curr Mol Med. 2022. PMID: 34645374 Review.
-
The Role of Cellular Immunity in the Protective Efficacy of the SARS-CoV-2 Vaccines.Vaccines (Basel). 2022 Jul 9;10(7):1103. doi: 10.3390/vaccines10071103. Vaccines (Basel). 2022. PMID: 35891267 Free PMC article. Review.
-
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021. Front Immunol. 2021. PMID: 35003131 Free PMC article.
Cited by
-
Post COVID-19 Symptoms Among Infected Vaccinated Individuals: A Cross-Sectional Study in Saudi Arabia.J Epidemiol Glob Health. 2023 Dec;13(4):740-750. doi: 10.1007/s44197-023-00146-9. Epub 2023 Sep 4. J Epidemiol Glob Health. 2023. PMID: 37665505 Free PMC article.
-
Genes, inflammatory response, tolerance, and resistance to virus infections in migratory birds, bats, and rodents.Front Immunol. 2023 Aug 29;14:1239572. doi: 10.3389/fimmu.2023.1239572. eCollection 2023. Front Immunol. 2023. PMID: 37711609 Free PMC article. Review.
References
-
- The World Health Organization . [(accessed on 21 October 2022)]. Naming the Coronavirus Disease (COVID-19) and the Virus That Causes It. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technica....
-
- Coronavirus Update Worldometer. [(accessed on 21 October 2022)]. Available online: https://www.worldometers.info/coronavirus/
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous